DIA:ARCA-SPDR Dow Jones Industrial Average (USD)

ETF | Large Value | NYSE Arca

Last Closing

USD 397.63

Change

+0.37 (+0.09)%

Market Cap

USD 13.20B

Volume

4.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Dow Jones Industrial Average (the ?DJIA?). The Trust?s Portfolio consists of substantially all of the component common stocks that comprise the DJIA, which are weighted in accordance with the terms of the Trust Agreement.

Inception Date: 13/01/1998

Primary Benchmark: DJ Industrial Average TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.17%

Management Expense Ratio: 0.17 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
CVE Cenovus Energy Inc 4.35 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-11 )

Largest Industry Peers for Large Value

Symbol Name Mer Price(Change) Market Cap
SCHD Schwab U.S. Dividend Equity ET.. 0.07 %

-0.96 (-1.17%)

USD 58.72B
DGRO iShares Core Dividend Growth E.. 0.08 %

-0.62 (-1.04%)

USD 28.81B
FNDX Schwab Fundamental U.S. Large .. 0.25 %

-1.52 (-2.21%)

USD 16.18B
SCHV Schwab U.S. Large-Cap Value ET.. 0.04 %

-1.29 (-1.69%)

USD 11.18B
SPYD SPDR® Portfolio S&P 500 High .. 0.08 %

-0.39 (-0.90%)

USD 6.33B
VOOV Vanguard S&P 500 Value Index F.. 0.15 %

-2.52 (-1.38%)

USD 5.00B
SPHD Invesco S&P 500® High Dividen.. 0.30 %

-0.05 (-0.10%)

USD 3.92B
FDVV Fidelity® High Dividend ETF 0.30 %

-0.45 (-0.94%)

USD 3.12B
IWX iShares Russell Top 200 Value .. 0.20 %

-1.18 (-1.52%)

USD 2.27B
LRGF iShares U.S. Equity Factor ETF 0.20 %

-1.13 (-2.03%)

USD 2.02B

ETFs Containing DIA

BAMO 19.53 % 0.00 %

N/A

N/A
DIP 9.65 % 0.00 %

N/A

N/A
LEXI Alexis Practical Tactical.. 4.98 % 0.00 %

-0.44 (0%)

USD 0.09B
DOCG:LSE L&G Healthcare Breakthrou.. 1.74 % 0.00 %

-26.50 (0%)

USD 0.07B
DOCT:LSE L&G Healthcare Breakthrou.. 1.74 % 0.00 %

-0.31 (0%)

USD 0.07B
HTEC Robo Global® Healthcare .. 0.00 % 0.00 %

-0.52 (0%)

USD 0.06B

Market Performance

  Market Performance vs. Industry/Classification (Large Value) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.51% 24% F 56% F
Dividend Return 0.91% 21% F 26% F
Total Return 6.42% 21% F 52% F
Trailing 12 Months  
Capital Gain 15.62% 69% C- 75% C
Dividend Return 1.75% 19% F 28% F
Total Return 17.37% 62% D 72% C
Trailing 5 Years  
Capital Gain 45.44% 52% F 72% C
Dividend Return 9.54% 22% F 36% F
Total Return 54.99% 51% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.66% 60% D- 69% C-
Dividend Return 11.34% 47% F 68% D+
Total Return 1.69% 29% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 14.77% 74% C 65% D
Risk Adjusted Return 76.80% 68% D+ 91% A-
Market Capitalization 13.20B 90% A- 92% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.